Financial Instruments (Tables)

9 Months Ended

May 28, 2021

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

Assets and liabilities measured at fair value on a recurring basis include the following (in thousands):

	Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Observable/ Unobservable Inputs Corroborated by Market Data (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Balances as of May 28, 2021:
Assets
Cash and cash equivalents	$	188,992	$	—	$	—	$	188,992
Total assets measured at fair value	$	188,992	$	—	$	—	$	188,992
Liabilities
Derivative financial instruments(1)	$	—	$	3,420	$	—	$	3,420
Acquisition-related contingent consideration (3)		—		—		44,500		44,500
Total liabilities measured at fair value	$	—	$	3,420		44,500	$	47,920
Balances as of August 28, 2020:
Assets
Cash and cash equivalents	$	150,811	$	—	$	—	$	150,811
Derivative financial instruments(2)		—		112		—		112
Total assets measured at fair value	$	150,811	$	112	$	—	$	150,923
Liabilities
Derivative financial instruments(1)	$	—	$	912	$	—	$	912
Total liabilities measured at fair value	$	—	$	912	$	—	$	912

(1) Included in other current liabilities on the Company’s condensed consolidated balance sheets - see Note 4.

(2) Included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets - see Note 4.

(3) Included in other long-term liabilities on the Company’s condensed consolidated balance sheets.